BeStock  
Stocks › Biotechnology › DMRA

Damora Therapeutics DMRA

US equityMarket cap rank #2901Biotechnology
$23.22 −$1.08 (-4.44%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $23.22 0.00%
Open$23.81
Prev close$24.30
Day range$23.13 – $24.51
Volume643.4K
Market cap$1.44B
P/E (TTM)13.6
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership115.0%+2.73 pts vs. prior quarter
Institutions holding131+7 vs. prior quarter
Insider trades (recent)34 buys / 11 sellsNet buying
Short interest7.60% of floatDays to cover 10.7 · as of 30 Oct 2026
Short-sale volume share22.6%5-day average of daily volume

Short-sale volume as % of daily volume

10%21%32%42%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$4.67M (6 inflow days, 14 outflow days).

Net flow by order size, last 20 sessions

−$4.8MSuper+$119.7KBig−$2.0MMid+$240.1KSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 47.1% of shares outstanding.

Largest holders

  • FMR15.43%
  • Fairmount Funds Management LLC14.07%
  • Avoro Capital Advisors LLC6.11%
  • VR Management, LLC5.82%
  • BlackRock5.68%
  • Forbion Capital Partners B.V.3.94%
  • RA Capital Management, L.P.3.88%
  • Viking Global Investors LP3.73%

By investor type

  • Mutual Fund48.98%
  • Hedge Fund38.47%
  • VC/PE Fund19.29%
  • Private Company6.71%
  • Public Company1.13%
  • Individual/Insider0.26%
  • Government Pension Fund0.18%
  • Insurance Company0.17%

Reported short interest has fallen from 7.68% to 7.60% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
BlackRock Mutual Fund 2026/Q3 +352,505 5.7%
Vanguard Capital Management, LLC Mutual Fund 2026/Q3 +344,895 0.9%
FMR Mutual Fund 2026/Q3 +316,077 15.4%
UBS Asset Management Mutual Fund 2026/Q3 +242,553 1.8%
Geode Capital Management, LLC Mutual Fund 2026/Q3 +237,922 1.9%
State Street Global Advisors Mutual Fund 2026/Q3 +235,397 2.9%
BMO Asset Management Mutual Fund 2026/Q3 +205,519 0.3%
Jennison Associates LLC Mutual Fund 2026/Q3 +153,109 0.2%
Jennifer Jarrett Individual/Insider 2026/Q3 +512,500 0.8%
Jennison Associates LLC Mutual Fund 2026/Q3 +153,109 0.2%
Nuveen Asset Management LLC Insurance Company 2026/Q3 +106,377 0.2%
BlackRock Mutual Fund 2026/Q3 +2,939,631 5.1%
J.P. Morgan Asset Management, Inc. Mutual Fund 2026/Q3 +2,009,849 3.3%
State Street Global Advisors Mutual Fund 2026/Q3 +1,361,578 2.5%
Blackstone Alternative Investment Advisors LLC Mutual Fund 2026/Q3 +1,002,971 1.6%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
24 Sep 2026 Jennifer Jarrett Chief Executive Officer Open Market Acquisition +12,500 $20.23 12,500
11 Aug 2026 Andrew Cheng Director Other Derivative Acquisition +30,350 $31.00 30,350
4 Aug 2026 Lori Firmani Former Chief Financial Officer Intent to Sell (Form 144) -1,800 $31.10 –
5 Jul 2026 Garrett Winslow Senior Vice President Derivative Exercise and Sale -245 $29.98 2,289
2 Jul 2026 Garrett Winslow Senior Vice President Derivative Exercise and Retained +435 – 2,289
21 Jun 2026 Lori Firmani Former Chief Financial Officer Intent to Sell (Form 144) -7,615 $25.36 –
30 Apr 2026 Brian Burkavage Senior VP of Finance, Principal Financial & Accounting Officer Initial Statement of Beneficial +0 – 312,535
29 Mar 2026 Jennifer Jarrett Chief Executive Officer Other Acquisition +500,000 – 500,000
29 Mar 2026 Jennifer Jarrett Chief Executive Officer Other Derivative Acquisition +1,500,000 $25.50 1,500,000
22 Mar 2026 Michael Landsittel Independent Director Other Derivative Acquisition +37,313 $23.05 37,313
22 Mar 2026 Christopher Cain Independent Director Other Derivative Acquisition +37,313 $23.05 37,313
22 Mar 2026 Garrett Winslow Senior Vice President Other Derivative Acquisition +250,000 $23.05 250,000
22 Mar 2026 Cameron Turtle Independent Director Other Derivative Acquisition +37,313 $23.05 37,313
22 Mar 2026 Peter Harwin Independent Chairperson Other Derivative Acquisition +37,313 $23.05 37,313
22 Mar 2026 Julianne Bruno Independent Director Other Derivative Acquisition +37,313 $23.05 37,313
8 Feb 2026 Fairmount Funds Management LLC Derivative Exercise and Retained +8,713,000 – 8,713,000
8 Feb 2026 Julianne Bruno Independent Director Derivative Exercise and Retained +129,000 – 137,032
4 Jan 2026 Becker Hewes Chief Medical Officer Other Acquisition +264,629 – 264,629
4 Jan 2026 Becker Hewes Chief Medical Officer Other Derivative Acquisition +528,603 $21.82 528,603
4 Jan 2026 Sherwin Sattarzadeh Chief Operating Officer Other Acquisition +190,376 – 190,376

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 4,689,717 7.6% 10.7
15 Oct 2026 5,152,194 8.3% 11.2
30 Sep 2026 4,733,297 7.7% 4.8
15 Sep 2026 4,732,463 7.7% 8.6
31 Aug 2026 4,131,367 6.7% 13.3
14 Aug 2026 4,739,939 7.7% 13.6

Discussion

No comments yet — be the first to weigh in on DMRA.

Sign in to join the discussion.

Scroll to Top